Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults. Mulligan MJ, Lyke KE, Kitchin N, Absalon J, et al. Nature 2020 Aug 12. pii: 10.1038/s41586-020-2639.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mulligan MJ, Lyke KE, Kitchin N, Absalon J, et al. Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 2020 Aug 12. pii: 10.1038/s41586-020-2639.
PMID: 32785213